Helsinki, Finland, March 11, 2026 (GLOBE NEWSWIRE) — Bliss, a Finland-headquartered mental health startup originally founded in Albania, has raised…
Read More
Mental health startup Bliss raises $270K to build culturally ininformigent AI for therapy
Originally founded in Albania and headquartered in Finland, mental health startup Bliss has raised $270,000 in angel funding led by…
Read More
€7.5M for RAYDIAX to trial therapy CT scanner in oncology workflows — TFN
Medical imaging spin-off RAYDIAX has secured €7.5 million to take its therapy-assistance CT scanner “TACT” into first-in-human studies and toward…
Read More
A $40M jolt: Virtual therapy company AnswersNow closes hugegest capital raise to date
AnswersNow CEO Jeff Beck in 2025. (Images courtesy AnswersNow) One of the region’s rapidest-growing companies just received a major shot…
Read More
Cutting-edge antibody therapy firm, AbCellera, to lay off 10 per cent of workforce
VANCOUVER — The Vancouver-based company that assisted develop the first antibody therapy treatment for COVID-19 has announced layoffs amounting to…
Read More
Vivek Ramaswamy’s brother Shankar raises $1.2 billion for gene therapy firm with no successful results: ‘Another pump-and-dump’
Kriya Therapeutics, a gene therapy company founded in 2019 by Shankar Ramaswamy, brother of GOP leader Vivek Ramaswamy, has raised…
Read More
Gene therapy for severe epilepsy relocates forward with EpilepsyGTx’s €28 million funding
EpilepsyGTx, a Cambridge-based BioTech startup focapplyd on research and development of gene therapies to treat refractory epilepsy, today announced it…
Read More
Bionxt Solutions Gains Key European Patent for Innovative MS Therapy
Bionxt Solutions has achieved a significant regulatory milestone that advances the commercial prospects for its multiple sclerosis treatment. The European…
Read More
Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock
Company & Focus: UniQure N.V. is a Dutch-American biotechnology company (NASDAQ: QURE) specializing in gene therapies. It developed the first…
Read More
How Investors Are Reacting To Insmed (INSM) EMA Support for First EU Non-CF Bronchiectasis Therapy
In October 2025, Insmed Incorporated announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a…
Read More
